PERSON DIRECTORY
Oliver Barnes
Oliver Barnes appears in 2 indexed conversations across Biotech Hangout. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
Episode 186 - June 12, 2026
Graig SuvannavejhEric SchmidtPaul MatteisOliver Barnes
Biotech is outperforming healthcare, with XBI up 10.5% year-to-date and Parabilis Medicines setting a $771M IPO record.Selective capital remains pivotal: Summit withdrew its $500M offering before the binary global HARMONi-3 readout, while Tango and Revolution reported a 90%+ response rate.Major deals and regulatory shifts offer catalysts, but financing needs, commercial competition, and follow-on capital allocation remain unresolved risks.
Episode 179 - April 10, 2026
Graig SuvannavejhJosh SchimmerYaron WerberSam FazeliOliver Barnes
XBI has rebounded 84% from its Liberation Day low to a fresh 52-week high, with financing and IPO activity pointing to improving risk appetite.Merck’s $6.7B Terns deal shows updated data can erase bidding leverage, while Gilead’s $3.15B Tubulis acquisition backs a differentiated ADC platform; Replimune’s second CRL leaves the FDA’s bar unclear, and obesity pricing competition remains a catalyst.